Invesco India Pharma and Healthcare Fund - Regular Plan - Growth
Invesco Asset Management (India) Private Ltd
₹9.36 (+1.52%)
NAV as of 9 Oct 2026
Minimum Investment: ₹1,000
Return
0.00% Returns for 1Y
Expense ratio & Others
- Net expense ratio
- —
- Exit load
- 0%
- Lock-in
- No
- Minimum investment
- ₹1,000
- Category
- Sector - Healthcare
Expense ratio is inclusive of GST. Returns may be taxed based on the fund type and your holding period — please read the scheme-related documents and consult a tax advisor. Figures are historical and do not guarantee future results.
Fund Returns Estimator
One-time investment
₹1,000
6 months
₹1,000
Invested ₹1,000
▲+0.00%1 year
₹1,000
Invested ₹1,000
▲+0.00%
Based on the fund’s historic trailing returns — a planning illustration, not a guarantee of future results.
Invest One-TimePlan it your way
The figures above are fixed to this fund’s past returns over set periods. Use a calculator to set your own amount, tenure and expected rate of return.
Risk level
Riskometer scale
- Low
- Low to Moderate
- Moderate
- Moderate to High
- High
- Very HighThis fund
Riskometer level assigned by the fund house as per SEBI norms. It can change as the scheme’s portfolio changes.
Fund benchmark
| Primary Index Name | BSE Healthcare PR INR |
|---|---|
| Secondary Index Name | BSE Healthcare PR INR |
| Index Name | BSE Healthcare TR INR |
| Weighting | 100% |
Returns
| 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|
| Fund returns (%) | +0.00% | — | — | — |
| Cumulative returns (%) | +0.00% | — | — | — |
Fund Manager
| Manager | Aditya Khemani |
|---|---|
| Role | Manager |
| Manager Tenure | 0.07 yrs |
About Fund
| Date of Incorporation | 7 Sep 2026 |
|---|---|
| Fund House | Invesco Asset Management (India) Private Ltd |
| Custodian | Deutsche Bank AG |
| Registrar / Transfer Agent | Invesco Asset Management (India) Private Ltd |
| Address | 1 Great Winchester Street |
Top Holdings
Holdings data is not available for this fund.
Investment Strategy
To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. The data shown is for information only and does not constitute investment advice.